Freyr · Account Report
Cortexa Biopharma
cortexabiopharma.com
Generated
Jul 22, 2026
Industry
Biotechnology
Geography
United States (Boston, MA)
Size
Mid-size
Owner
Mark Miller
Competitor
—
Open value
$260K
Account summary
Clinical-stage neuro biotech, ~300 staff, two Phase 2 CNS assets, first EMA filing planned.
Buying committee (1)
- Marcus ThorneHead of CMC
Deals (1)
- NDA/MAA CMC WritingQualified · $260K
Recommended Freyr services
- NDA/MAA CMC Writing
- Regulatory Intelligence
Recent activity
- Interested — Keen on CTD/CMC support for the EMA filing.Jul 16, 2026 • 6:00 PM